Specific features of treatment of supraventricular form of paroxysmal tachycardia in children
Abstract
The analysis of hospital treatment of pediatric patients with supraventricular form of paroxysmal tachycardia (PT) was carried out in comparison with the approaches and results of the treatment of foreign colleagues; case histories of patients with this disease were studied and case monitoring was performed. At the same time, the main drugs for rapid relief of symptoms and prophylactic treatment of PT were determined taking into account their effectiveness. For routine preventive therapy of PT attacks beta-blockers should be primarily used, then propafenone is recommended and, taking into account the side effects, cordarone should be employed. In the early age, the most effective combination is the use of antiarrhythmic drugs. Approaches to the treatment and follow up of children with PT in the Republic of Belarus correspond to the world level and are comparable with the results of foreign studies.
About the Authors
E. V. SechkoBelarus
E. V. Zasim
Belarus
V. V. Strogiy
Belarus
N. I. Saviuk
Belarus
References
1. Сечко Елена Владимировна – врач педиатрического отделения №2(для кардиоревматологических больных) УЗ «2–я детская клиническая больница», 220020 г. Минск, ул. Нарочанская, 17, (017) 369–50–51, elena_sechko@mail.ru
2. Засим Елена Владимировна – заведующая консультативно–поликлиническим отеделением отдела детской кардиохирургии ГУ «РНПЦ детской хирургии», аритмолог, (017) 290–21–86 , пр. Независимости, 64, Республика Беларусь, 220013, г. Минск,
3. Строгий Владимир Владимирович – д.м.н., доцент, зав. кафедрой пропедевтики детских болезней УО «БГМУ», 220118, ул. Шишкина, д.24, г. Минск, тел. (017) 3417288, vstrogiy@rambler.ru, моб.тел. +3750296394624
4. Савьюк Н.И. – студент 5 курса педиатрического факультета УО «БГМУ», troddy56@gmail.com.
Review
For citations:
Sechko E.V., Zasim E.V., Strogiy V.V., Saviuk N.I. Specific features of treatment of supraventricular form of paroxysmal tachycardia in children. Emergency Cardiology and Cardiovascular Risks journal. 2018;2(1):190-195. (In Russ.)









